Cargando…

Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population

Herpes zoster (HZ) vaccination is approved for adults aged 50+ for the prevention of HZ, but it is underutilized. The objective of this study was to evaluate the association between out-of-pocket cost and HZ vaccine utilization. Adults aged 65 or older enrolled for at least 12 months in Medicare Adv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Zhuliang, Li, Yong, Stemkowski, Stephen, Johnson, Kelly D., Acosta, Camilo J., Zhang, Dongmu, Fendrick, A. Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313857/ https://www.ncbi.nlm.nih.gov/pubmed/30469449 http://dx.doi.org/10.3390/vaccines6040078

Ejemplares similares

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Progressivity of out-of-pocket costs for Medicare-subsidised services and medicines in Australia.
por: Di Law, Hsei, et al.
Publicado: (2022)

Herpes Zoster-Attributable Resource Utilization and Cost Burden in Patients With Solid Organ Transplant
por: Palmer, Liisa, et al.
Publicado: (2014)

The epidemiology of herpes zoster and its complications in Medicare cancer patients
por: Yenikomshian, Mihran A, et al.
Publicado: (2015)

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products
por: Gupta, Arjun, et al.
Publicado: (2022)

Duration of Antiviral Prophylaxis and Risk of Herpes Zoster among Patients Receiving Autologous Hematopoietic Stem Cell Transplants: A Retrospective, Observational Study
por: Zhang, Dongmu, et al.
Publicado: (2017)

Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Cost-Effectiveness of Herpes Zoster Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2019)

Patterns of Care in Patients with Metastatic Renal Cell Carcinoma Among a U.S. Payer Population with Commercial or Medicare Advantage Membership
por: Miller, Lesley-Ann, et al.
Publicado: (2016)

Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?
por: Fong, Joelle H.
Publicado: (2019)

Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective
por: Graham, Jonathan, et al.
Publicado: (2016)

Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009)

Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke
por: Salam, Tabassum, et al.
Publicado: (2023)

Annual incidence rates of herpes zoster among an immunocompetent population in the United States
por: Johnson, Barbara H., et al.
Publicado: (2015)

16. Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2021)

1046 Economic Burden of Herpes Zoster by Age Group in Immunocompetent Patients in the United States
por: Gatwood, Justin, et al.
Publicado: (2014)

Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D
por: Trish, Erin, et al.
Publicado: (2021)

Systematic review of incidence and complications of herpes zoster: towards a global perspective
por: Kawai, Kosuke, et al.
Publicado: (2014)

ENTERING MEDICARE ADVANTAGE FROM EMPLOYER-SPONSORED PLANS: CHANGE IN OUT-OF-POCKET COSTS AND UTILIZATION AT AGE 65
por: Hames, Alexandra Glynn, et al.
Publicado: (2022)

Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2022)

Herpes Zoster
por: Warneros Loyo, María de Lourdes
Publicado: (1995)

Herpes Zoster
Publicado: (1890)

Herpes Zoster
por: Wile, Henry
Publicado: (1886)

Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France
por: Blein, Cecile, et al.
Publicado: (2015)

Out-of-Pocket Costs of Diagnostic Breast Imaging Services After Screening Mammography Among Commercially Insured Women From 2010 to 2017
por: Lowry, Kathryn P., et al.
Publicado: (2021)

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
por: Galaznik, Aaron, et al.
Publicado: (2014)

Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline
por: Suehs, Brandon T., et al.
Publicado: (2014)

Herpes Zoster / Revisión Bibliográfica /
por: Escamilla Sánchez, Jacqueline
Publicado: (1993)

RELATION OF VARICELLA TO HERPES ZOSTER : I. STATISTICAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Herpes Zoster Ophthalmicus
por: Catron, Thomas, et al.
Publicado: (2008)

Necrodestructive Herpes Zoster
por: Gupta, Sanjeev, et al.
Publicado: (2012)

Herpes zoster in infancy
por: Gupta, Lalit Kumar, et al.
Publicado: (2013)

Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013)

Is Herpes Zoster Contagious?
Publicado: (1885)

The Pathology of Herpes Zoster
Publicado: (1908)

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Sulphanilamide
por: Biswas, J. C.
Publicado: (1942)

Cannot write session to /tmp/vufind_sessions/sess_0dc5mcccaaqkvn3esibfmhgnu0